Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
基本信息
- 批准号:6630241
- 负责人:
- 金额:$ 14.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-15 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis Shigella actins bacteria infection mechanism bacterial cytopathogenic effect bacterial proteins biological signal transduction cytoskeleton genetically modified animals guanine nucleotide binding protein guanosinetriphosphatases host organism interaction intestinal mucosa laboratory mouse membrane proteins pathologic process protein structure function site directed mutagenesis
项目摘要
DESCRIPTION (provided by applicant): Shigella are gram negative enteric pathogens that cause severe diarrheal disease and have been classified as a Category B Biological Agent. Shigella pathogenesis requires bacterial invasion of the colonic epithelium and bacterial spread through the colonic mucosa. Shigella entry into epithelial cells is mediated by effector molecules, secreted through a type III secretion apparatus, that activate Rho family GTPase signaling pathways to induce the formation of cell surface projections and membrane ruffles that engulf the bacteria by macropinocytosis. Both Cdc42 and Rac have been implicated as having a role in the Shigella entry process. Cdc42 is known to activate Rac; it is not clear whether Cdc42 involvement in Shigella entry is mediated exclusively via this link. Moreover, the downstream effectors of Cdc42 and/or Rac activation during Shigella entry are unknown. We have recently confirmed that the major Shigella pathway is Cdc42-dependent. However, we have also demonstrated the existence of a novel Cdc42-independent invasion pathway. Furthermore we have shown that the only known downstream effector of Cdc42 that activates the actin cytoskeleton, N-WASP, is not involved in Shigella entry. Once in the cytoplasm, Shigella moves by active assembly of an actin tail. Actin tail formation is mediated by the Shigella outer membrane protein IcsA, which binds and activates N-WASP. Activated N-WASP stimulates Arp2/3 complex-mediated actin assembly. The molecular mechanism by which IcsA binds and activates N-WASP is poorly understood.
Our goals in this proposal are to:
1. Define the specific roles of Cdc42 and Rac in Shigella entry;
2. Identify and characterize the downstream effectors of Rho family activation during Shigella entry; and,
3. Elucidate the mechanism(s) by which Shigella IcsA activates N-WASP and determine whether this mechanism mimics Cdc42 activation of N-WASP
These studies will define the specific cellular signaling pathways required for Shigella entry and actin tail formation and will identify downstream pathways of Rho family activation.
描述(由申请人提供):志贺氏菌是革兰氏阴性肠道病原体,可引起严重腹泻病,已被归类为 B 类生物制剂。志贺氏菌的发病机制需要细菌侵入结肠上皮并通过结肠粘膜传播。志贺氏菌进入上皮细胞是由效应分子介导的,通过 III 型分泌装置分泌,激活 Rho 家族 GTP 酶信号通路,诱导细胞表面突起和膜皱褶的形成,通过巨胞饮作用吞噬细菌。 Cdc42 和 Rac 都被认为在志贺氏菌进入过程中发挥了作用。已知 Cdc42 可以激活 Rac;目前尚不清楚 Cdc42 参与志贺氏菌进入是否仅通过此链接介导。此外,志贺氏菌进入过程中 Cdc42 和/或 Rac 激活的下游效应器尚不清楚。我们最近证实志贺氏菌的主要途径是 Cdc42 依赖性的。然而,我们还证明了一种新的不依赖于 Cdc42 的入侵途径的存在。此外,我们还表明,激活肌动蛋白细胞骨架的唯一已知的 Cdc42 下游效应子 N-WASP 不参与志贺氏菌的进入。一旦进入细胞质,志贺氏菌就会通过肌动蛋白尾部的主动组装来移动。肌动蛋白尾部的形成由志贺氏菌外膜蛋白 IcsA 介导,IcsA 结合并激活 N-WASP。激活的 N-WASP 刺激 Arp2/3 复合物介导的肌动蛋白组装。 IcsA 结合并激活 N-WASP 的分子机制尚不清楚。
我们在此提案中的目标是:
1.明确Cdc42和Rac在志贺氏菌条目中的具体作用;
2. 鉴定和表征志贺氏菌进入过程中Rho家族激活的下游效应子;和,
3. 阐明志贺菌 IcsA 激活 N-WASP 的机制,并确定该机制是否模仿 Cdc42 激活 N-WASP
这些研究将定义志贺氏菌进入和肌动蛋白尾部形成所需的特定细胞信号传导途径,并将确定 Rho 家族激活的下游途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott B Snapper其他文献
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
抗肿瘤坏死因子α在极早发炎症性肠病中的功效和安全性。
- DOI:
10.1093/ibd/izad196 - 发表时间:
2023 - 期刊:
- 影响因子:4.9
- 作者:
L. Collen;V. Mitsialis;David Y. Kim;Mairead Bresnahan;Jessica Yang;M. Tuthill;A. Combs;J. Barends;M. Field;Enju Liu;R. Bearup;I. Okoroafor;Christoph Klein;A. Muise;A. Bousvaros;J. Ouahed;Scott B Snapper - 通讯作者:
Scott B Snapper
Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort
罕见疾病队列中深度学习模型与临床级变异致病性分类之间的不一致
- DOI:
10.1101/2024.05.22.24307756 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
S. Kong;In;Lauren V Collen;Arjun K Manrai;Scott B Snapper;Kenneth D Mandl - 通讯作者:
Kenneth D Mandl
Scott B Snapper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott B Snapper', 18)}}的其他基金
Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.
采用新型人源化小鼠品系开发造血干细胞基因治疗方法,用于治疗因 IL10 受体缺陷所致的极早发炎症性肠病。
- 批准号:
9535567 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Type III interferon Control of Mucosal Immunity
III 型干扰素控制粘膜免疫
- 批准号:
10587625 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
8232674 - 财政年份:2011
- 资助金额:
$ 14.81万 - 项目类别:
Deciphering the Role of WASP Family Proteins in T Cell Function
解读 WASP 家族蛋白在 T 细胞功能中的作用
- 批准号:
8147996 - 财政年份:2010
- 资助金额:
$ 14.81万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
7877475 - 财政年份:2009
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6800508 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6833455 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7161772 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7012813 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
The Pathogenesis Of Colitis In A Novel Th2 Model Of IBD
新型 IBD Th2 模型中结肠炎的发病机制
- 批准号:
6418028 - 财政年份:2002
- 资助金额:
$ 14.81万 - 项目类别:
相似国自然基金
Shigella sp. PIB菌产生长链脂肪酸诱发顽固性功能性便秘的机制研究
- 批准号:32371176
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IBD原籍菌Shigella通过Neu5Ac碳源竞争拮抗外源Faecalibacterium定植导致FMT后肠黏膜修复抑制的机制研究
- 批准号:82300753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
志贺氏菌外膜蛋白及0抗原多糖的致病作用分析
- 批准号:39370040
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
志贺氏菌属耐药性质粒消除的研究
- 批准号:38671148
- 批准年份:1986
- 资助金额:0.5 万元
- 项目类别:面上项目
相似海外基金
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
- 批准号:
10646015 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Characterization of virulence factors in shigellosis
志贺氏菌病毒力因子的表征
- 批准号:
10724770 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Shigella mediated regulation of epithelial cell inflammasomes
志贺氏菌介导的上皮细胞炎症小体的调节
- 批准号:
10608342 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Spatiotemporal Regulation of Protrusion Dynamics During Intracellular Bacterial Dissemination
细胞内细菌传播过程中突起动力学的时空调节
- 批准号:
10740577 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
The role of the tuft cell inflammasome in infection
簇细胞炎症小体在感染中的作用
- 批准号:
10418402 - 财政年份:2022
- 资助金额:
$ 14.81万 - 项目类别: